Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan’s Optometry Device Maker Nidek Invests In Biopharma Ventures

This article was originally published in PharmAsia News

Executive Summary

Japan Science and Technology Agency announced the establishment of Bioresource Application Institute. With a capital of ¥200 million ($2.0 million), BRA Institute is funded by Aichi, Japan-based ophthalmology and optometry device maker Nidek and Kitasato University professor Noruo Sakuragawa. The new company will utilize Sakuragawa's research on amniotic cells, which found a site population cell with stem-cell functions; the cell is expected to be used in gene therapy and to treat infertility. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067970

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel